OHIS
REGN icon

Oak Harvest Investment Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Oak Harvest Investment Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,779
Closed -$2.92M – 170
2024
Q3 		$2.92M Buy
2,779
+567
+26% +$631K 0.42% 67
2024
Q2 		$2.32M Buy
2,212
+435
+24% +$422K 0.36% 68
2024
Q1 		$1.71M Buy
1,777
+566
+47% +$538K 0.28% 73
2023
Q4 		$1.06M Buy
1,211
+247
+26% +$203K 0.21% 76
2023
Q3 		$793K Sell
964
-12
-1% -$9.43K 0.17% 72
2023
Q2 		$701K Sell
976
-1,777
-65% -$1.37M 0.16% 71
2023
Q1 		$2.26M Sell
2,753
-79
-3% -$59.6K 0.52% 55
2022
Q4 		$2.04M Buy
2,832
+58
+2% +$42.8K 0.53% 50
2022
Q3 		$1.91M Buy
+2,774
New +$1.75M 0.51% 51

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Oak Harvest Investment Services's REGN Position: Q4 2024 in Review

Oak Harvest Investment Services sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 2,779 shares — an estimated $2.92M sold.

Oak Harvest Investment Services first reported a position in REGN in Q3 2022 and held it in 9 quarters. The position peaked at $2.92M in Q3 2024. 1,318 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • Oak Harvest Investment Services reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Oak Harvest Investment Services sold 2,779 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $2.92M.
  • Oak Harvest Investment Services first reported a position in Regeneron Pharmaceuticals in Q3 2022 and held it in 9 quarters.
  • Oak Harvest Investment Services's Regeneron Pharmaceuticals position peaked at $2.92M in Q3 2024.
  • 1,318 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Oak Harvest Investment Services's 13F filing for Q4 2024, filed 23 Jan 2025.